Pressure on middlemen to stop cutting secret drug deals

12/22/2003 | NYTimes.com

Pharmacy benefit managers are under increasing pressure from government, big employers and some drug makers to end secret deals with pharmaceutical companies that sometimes favor expensive drugs over cheaper generics. The call for more transparency will grow louder if the companies manage the new Medicare drug benefit, one Medicare expert said.

View Full Article in:

NYTimes.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Compliance and Ethics Director
Sysmex America, Inc.
Lincolnshire, IL
Director, Site Quality Management
CareFusion
Palm Springs, CA
Compliance Officer-Medical Products
W. L. Gore
Flagstaff, AZ
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC